Skip to content
Our Company
Culture and Values
Leadership
Corporate Impact
Environmental, Social, and Governance
Product Donations
Charitable Giving
CME and Research Grants
Careers
Open Roles
Life at Emergent
Locations
Our Focus
Biological Threats
Opioid Crisis
Manufacturing Partnerships
Our Science
Pipeline
Our Products
Product and Medical Inquiries
Latest
Press Releases
Blog
Podcast
Media Statements
Media Resources
Investors
FOLLOW US
Press Releases
August 7, 2008
Emergent BioSolutions Reports Financial Results for Second Quarter 2008
...
Read More
August 5, 2008
Emergent BioSolutions to Present at the BMO Capital Markets Focus on Healthcare Conference on August 6, 2008
...
Read More
July 31, 2008
Emergent BioSolutions Submits Proposal in Response to HHS RFP for Development and Procurement of a Recombinant Protective Antigen Anthrax Vaccine
...
Read More
July 29, 2008
Statement by Emergent BioSolutions in Response to Attempt by Protein Sciences Corporation to Terminate Asset Purchase Transaction
...
Read More
July 25, 2008
Emergent BioSolutions to Release Second Quarter 2008 Financial Results and Conduct a Conference Call on August 7, 2008
...
Read More
July 24, 2008
Emergent BioSolutions Awarded Two Grants from NIAID to Support Development of the Company’s Recombinant Botulinum Vaccine (rBOT) and Next Generation Anthrax Vaccine (NGAV) Candidates
...
Read More
July 23, 2008
Emergent BioSolutions and the University of Oxford Form Joint Venture to Develop an Advanced Tuberculosis Vaccine with Funding from Wellcome Trust and Aeras Global TB Vaccine Foundation
...
Read More
July 9, 2008
Emergent BioSolutions Initiates Lawsuit Against Protein Sciences and Its Senior Management Regarding Delayed Asset Acquisition
...
Read More
June 5, 2008
Emergent BioSolutions and the European Corporate Security Association (ECSA) Sponsor a Conference on Bioterrorism
...
Read More
June 5, 2008
Emergent BioSolutions Initiates U.S. Phase II Trial of Oral Typhoid Vaccine Candidate
...
Read More
June 4, 2008
Emergent BioSolutions to Webcast Presentation at the Jefferies and Company 2nd Annual Healthcare Conference on June 25, 2008
...
Read More
May 27, 2008
Emergent BioSolutions to Acquire Protein Sciences’ Phase III Recombinant Flu Vaccine Candidate, FluBlok(R), and Related Novel Platform Technology
...
Read More
1
2
…
51
52
53
…
58
59
